New Screening Tool Predicts Likelihood Of Prostate Cancer April 2, 2015 / 4:24 PM EDT / CBS Miami Each year, more than one million men in the United States have a prostate biopsy due to an ...

Greenville Health System urologists will talk about the latest options for treating prostate cancer at free Lunch and Learn events on Sept. 17 at 11:30 a.m. at the Green Valley Country Club and ...

News provided by EIN Presswire May 23, 2024, 7:45 AM ET PSMA PET-CT is a diagnosit tool helping save men's lives with prostate cancer that has spread beyond the prostate gland ...

Dr. Simon and colleagues are currently working on an extension of this research that would provide a decision-making tool for men over 40 in the initial stages of prostate screening.

“The updated NCCN Prostate Cancer Guidelines continue to solidify Prolaris' market position,” said Paul J. Diaz, President and CEO, Myriad Genetics.

Johns Hopkins Medicine. "Updated tool now available to predict prostate cancer spread." ScienceDaily. ScienceDaily, 3 January 2013. <www.sciencedaily.com / releases / 2013 / 01 / 130103073050.htm>.

The FDA has authorized the ArteraAI Prostate Test to prognosticate long-term outcomes in patients with non-metastatic prostate cancer.